US 8414890
Human antibodies to human RANKL, encoding nucleic acids and methods of treatment
granted A61KA61K2039/505A61P
Quick answer
US patent 8414890 (Human antibodies to human RANKL, encoding nucleic acids and methods of treatment) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61P, A61P19/00, A61P19/02